Precigen (PGEN) Net Margin (2012 - 2026)

Precigen's (PGEN) quarterly Net Margin came in at 34.1% in Q1 2026, up 400415.0% year-on-year from N/an in Q1 2025, and up 88.59% on a QoQ basis from 298.79% in Q4 2025.

Precigen (PGEN) Net Margin (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 14 years of Net Margin data on file, last reported at 34.1% in Q1 2026.

  • On a quarterly basis, Net Margin rose 400415.0% year-over-year to 34.1% in Q1 2026; TTM through Mar 2026 was 1167.5%, a 155732.0% increase from a year earlier, with the FY2025 full-year figure at 4436.62%, down 122044.0% from the prior year.
  • Net Margin for Q1 2026 stood at 34.1%, up from 298.79% in the prior quarter.
  • Over the last five years, Net Margin for PGEN reached as high as 649.77% in Q3 2022 and fell as low as 2397800.0% in Q3 2024.
  • Historically, Net Margin has averaged 204171.65% across 4 years, with a median of 1381.76% in 2024.
  • On a YoY basis, Net Margin climbed as much as 236326242 bps in 2025 and fell as far as 180933 bps in 2025.
  • Year by year, Net Margin stood at 649.77% in 2022, then tumbled by 182 bps to 534.61% in 2024, then soared by 44 bps to 298.79% in 2025, then soared by 89 bps to 34.1% in 2026.
  • Per Business Quant data, the three most recent Net Margin figures were 34.1% in Q1 2026, 298.79% in Q4 2025, and 34537.58% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn -34.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 -34.10%
Dec 31, 2025 -298.79%
Sep 30, 2025 -34,537.58%
Jun 30, 2025 -3,411.27%
Mar 31, 2025 -4,038.26%
Dec 31, 2024 -534.61%
Sep 30, 2024 -2,397,800.00%
Jun 30, 2024 -8,199.72%
Mar 31, 2024 -2,228.92%
Sep 30, 2022 649.77%
Jun 30, 2022 289.39%
Mar 31, 2022 84.29%
Dec 31, 2021 -16.51%
Sep 30, 2021 -103.36%
Jun 30, 2021 285.43%
Mar 31, 2021 18.47%
Dec 31, 2020 -6.78%
Sep 30, 2020 -8.36%
Jun 30, 2020 -90.87%
Mar 31, 2020 -117.81%